A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 85, Issue 3 PART A, 2013, Pages 711-715

  Özcetin, Aybike ^a   Aigner, Achim ^b   Bakowsky, Udo ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angiogenesis; Anti angiogenesis; CAM assay; Chorioallantoic membrane; Imatinib; Tyrosine kinase inhibitor

Indexed keywords

ABELSON KINASE; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; BCR ABL PROTEIN; GELFOAM; IMATINIB; MATRIGEL;

ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL; BLOOD VESSEL DIAMETER; CANCER INHIBITION; CELL SUSPENSION; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG MECHANISM; NONHUMAN; PROTEIN SECRETION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; TUMOR GROWTH; TUMOR MODEL; TUMOR XENOGRAFT;

ANGIOGENESIS; ANTI-ANGIOGENESIS; CAM ASSAY; CHORIOALLANTOIC MEMBRANE; IMATINIB; TYROSINE KINASE INHIBITOR;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BENZAMIDES; CELL LINE, TUMOR; CHORIOALLANTOIC MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; GELATIN; GELATIN SPONGE, ABSORBABLE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MICE; NEOVASCULARIZATION, PATHOLOGIC; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84888368183     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.07.010     Document Type: Article

References (10)

1. M. Klagsbrun, and P. D'Amore Regulators of angiogenesis Annu. Rev. Physiol. 53 1991 217 239
2. J. Folkman Anti-angiogenesis: new concept for therapy of solid tumors Ann. Surg. 175 1972 409 416
3. J.P. Chizea, V.K. Dailey, E. Williams, M.D. Johnson, R.G. Pestell, and J.O. Ojeifo Endothelial progenitor cells significantly contribute to vasculatures in human and mouse breast tumors The Open Hematol. J. 1 2008 30 62
4. W. Leene, M.J.M. Duyzings, and C. Von Steeg Lymphoid stem cell identification in the developing thymus and bursa of Fabricius of the chick Z. Zellforsch. 136 1973 521 533
5. D. Ribatti, A. Gualandris, M. Bastaki, A. Vacca, M. Iuraro, L. Roncali, and M. Presta New model for the study of angiogenesis antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatine sponge/chorioallantoic membrane assay J. Vasc. Res. 34 1997 455 463
6. J. Folkman Tumor angiogenesis factor Cancer Res. 34 1974 2109 2113
7. E. Buchdunger, T. O'Reilly, and J. Wood Pharmacology of Imatinib (STI571) Eur. J. Cancer 38 5 2002 28 36
8. M.L. Ebos, J. Tran, Z. Master, D. Dumont, J.V. Melo, E. Buchdunger, and R.S. Kerbel Imatinib mesylate (STI571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia Mol. Cancer. Res. 1 2002 89 95
9. A. Ostman PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma Cytokine Growth Factor Rev. 15 2004 275 286
10. D. Ribatti Chick embryo chorioallantioic membrane as a useful tool to study angiogensis Int. Rev. Cell Mol. Biol. 270 2009 181 224